Innovative Presentations and Demonstrations at RSNA 2025
Nanox Imaging Ltd, a leading provider of advanced medical imaging technologies, is set to unveil its groundbreaking Nanox.ARC X system at the Radiological Society of North America (RSNA) 2025 Annual Meeting. This prestigious event, scheduled for the end of November through early December, will take place in Chicago, bringing together medical professionals and innovators in radiology.
Live Demonstrations of the Nanox.ARC X
The standout feature of this year's RSNA meeting will be live demonstrations of the Nanox.ARC X. Attendees can visit Booth #3914 in South Hall Level 3 to experience the capabilities of this AI-ready multi-source digital tomosynthesis system. Demonstrations will be conducted every 30 minutes, showcasing how this technology provides advanced imaging solutions with significantly lower costs and radiation exposure compared to traditional CT scans.
The Future of AI in Radiology
During the Innovation Theater presentation happening on December 2, 2025, at 11:00 AM at Booth #3316, Dr. Orit Wimpfheimer, the Chief Medical Officer of Nanox, will discuss the integration of an AI solution aimed at enhancing pulmonary nodule detection. This development is a significant step forward, promising to improve diagnostic accuracy and patient outcomes.
Exciting Networking Opportunities
The RSNA 2025 meeting will not only present groundbreaking technology but also provide invaluable networking opportunities. Dr. Lawrence Tanenbaum will host a cocktail event set for December 1, where discussions will revolve around the future implications of AI in radiology. This event promises to gather industry leaders and innovators, fostering collaboration and dialogue.
Clinical Data Presentations
In addition to live demonstrations, Nanox will present clinical data that highlights the effectiveness of digital tomosynthesis across various applications, including musculoskeletal imaging and other vital health indicators. This data will underline the efficacy of the Nanox.ARC X in real-world settings, providing insights that could significantly influence clinical practices.
Educational Posters at the RSNA
Another exciting component of Nanox's participation at RSNA 2025 includes the educational exhibit focused on the “Applications of Digital Tomosynthesis in the Musculoskeletal System.” This poster presentation will feature contributions from leading professionals in the field, offering evidence-based insights into the technology's benefits.
About Nanox and Its Mission
With a commitment to transforming healthcare accessibility, Nanox (NASDAQ: NNOX) focuses on delivering affordable medical imaging solutions driven by advanced technologies. The Nanox.ARC serves as the platform for their innovation, integrating proprietary digital X-ray sources and AI algorithms to facilitate early detection of chronic diseases. The Company envisions a future where medical imaging is not only accessible but also seamlessly incorporates artificial intelligence to enhance diagnosis and treatment.
Frequently Asked Questions
What is the Nanox.ARC X?
The Nanox.ARC X is an AI-ready multi-source digital tomosynthesis system designed to provide advanced 3D imaging at lower costs and radiation doses compared to traditional CT scans.
When and where can I see live demonstrations of Nanox.ARC X?
Live demonstrations will take place every 30 minutes at Booth #3914 in South Hall Level 3 during the RSNA 2025 Annual Meeting.
Who will present at the Innovation Theater?
Dr. Orit Wimpfheimer, the Chief Medical Officer of Nanox, will present on December 2, focusing on AI solutions for pulmonary nodule detection.
What networking opportunities will be available at RSNA 2025?
Nano representatives, including Dr. Lawrence Tanenbaum, will host a cocktail event on December 1, providing an excellent opportunity for discussions about the future of radiology and AI.
How does Nanox aim to improve healthcare outcomes?
Nanox aims to enhance healthcare outcomes by implementing affordable imaging technologies and AI solutions that support early detection and treatment of diseases, ultimately improving patient care.